File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Treatment-Related Adverse Events of Combination EGFR Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitor in EGFR-Mutant Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

TitleTreatment-Related Adverse Events of Combination EGFR Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitor in EGFR-Mutant Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
Authors
Chan, DChoi, CWLee, VHF
Issue Date2022
Citation
Cancers, 2022, v. 14, p. 2157 How to Cite?
DOI: http://dx.doi.org/10.3390/cancers14092157
Persistent Identifierhttp://hdl.handle.net/10722/316738
ISI Accession Number ID
WOS:000794417100001

 

DC FieldValueLanguage
dc.contributor.authorChan, D-
dc.contributor.authorChoi, CW-
dc.contributor.authorLee, VHF-
dc.date.accessioned2022-09-16T07:22:31Z-
dc.date.available2022-09-16T07:22:31Z-
dc.date.issued2022-
dc.identifier.citationCancers, 2022, v. 14, p. 2157-
dc.identifier.urihttp://hdl.handle.net/10722/316738-
dc.languageeng-
dc.relation.ispartofCancers-
dc.titleTreatment-Related Adverse Events of Combination EGFR Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitor in EGFR-Mutant Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis-
dc.typeArticle-
dc.identifier.emailChoi, CW: hcchoi@hku.hk-
dc.identifier.emailLee, VHF: vhflee@hku.hk-
dc.identifier.authorityChoi, CW=rp02815-
dc.identifier.authorityLee, VHF=rp00264-
dc.identifier.doi10.3390/cancers14092157-
dc.identifier.hkuros336883-
dc.identifier.volume14-
dc.identifier.spage2157-
dc.identifier.epage2157-
dc.identifier.isiWOS:000794417100001-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats